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Edited by Miguel De la RosaAbstract In this study, we report that a single mutation of cys-
teine 18 to isoleucine (C18I) in Escherichia coli Hha abolishes
the repression of the hemolysin operon observed in the wild-type
protein. The phenotype also includes a signiﬁcant decrease in the
growth rate of E. coli cells at low ionic strength. Other substitu-
tions at this position (C18A, C18S) have no observable eﬀects in
E. coli growth or hemolysin repression. All mutants are stable
and well folded and bind H–NS in vitro with similar aﬃnities
suggesting that Cys 18 is not directly involved in H–NS binding
but this position is essential for the activity of the H–NS/Hha
heterocomplexes in the regulation of gene expression.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Transcription repression1. Introduction
Proteins of the H–NS family are widely conserved in Gram-
negative bacteria. Best characterized in Escherichia coli, H–NS
is a good example of a nucleoid-associated protein exhibiting
dual function: it contributes to the chromosomal architecture
and, when binding to speciﬁc promoter regions, generates
nucleoprotein complexes that inhibit transcription [1]. Recent
studies based on transcriptomic approaches have shown that,
in addition to modulate housekeeping genes, H–NS plays a rel-
evant role silencing large AT-rich DNA stretches that may
have been acquired by lateral gene transfer [2–4].
H–NS shows two distinct domains connected by a ﬂexible
linker. The C-terminal domain is involved in DNA binding.Abbreviations: EDTA, ethylene diamine tetraacetic acid; HSQC,
heteronuclear single-quantum correlation; IPTG, isopropyl b-D-
thiogalactoside; LB, Luria–Bertani; MTSL, (1-oxyl-2,2,5,5-tetra-
methyl-3-pyrroline-3-methyl)-methanethiosulfonate; TCEP, tris(2-car-
boxyethyl)-phosphine
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doi:10.1016/j.febslet.2008.07.037The N-terminal domain confers the protein the ability to par-
ticipate in protein–protein interactions. In addition to generate
homoligomers, H–NS is also able to interact with other pro-
teins, generating heteromeric compounds. Proteins interacting
with H–NS may contain protein- and DNA-binding domains,
as its paralogue StpA [5], or just protein-binding domains, as
the members of the Hha/YmoA family of proteins. Proteins
of this latter family coregulate with H–NS several virulence
determinants in enteric bacteria [6,7]. For example, the interac-
tion with Hha enhances the ability of H–NS to repress, under
non-permissive conditions, the E. coli hly operon encoding the
hemolysin toxin [6].
The three-dimensional structure of Hha [8] consists of four
alpha-helical segments separated by loops (Fig. 1). Previous
NMR results from our group suggested that the interaction be-
tween Hha and H–NS64 (fragment containing the ﬁrst 64 res-
idues of H–NS) induced a conformational rearrangement of
Hha exposing residues deeply buried in its hydrophobic core
[9]. Similar eﬀects were observed in Hha by temperature per-
turbation even in the absence of H–NS. In this case, no major
changes in the helix content could be detected by circular
dichroism suggesting that the Hha intrinsic plasticity is most
likely related to the loops linking the helical segments.
Under the hypothesis that a helix packing rearrangement
may be relevant for Hha function, we reasoned that the loop
between helices H1 and H2 could be especially important as
its size is intermediate between that of the sharp turn linking
helices H2 and H3 and the very ﬂexible loop that connects heli-
ces H3 and H4. Among the loop residues connecting helices
H1 and H2 we focussed our attention in the highly conserved
single cysteine residue in position 18. This cysteine is not in-
volved in metal binding or disulﬁde bond formation, at least
in the context of H–NS binding, which takes place in the pres-
ence of ethylene diamine tetraacetic acid (EDTA) and reducing
agents. An exception to the conservation of this residue is
found in the Hha paralogue YdgT, which forms strong com-
plexes with H–NS and has an isoleucine residue at position
18 [10].
We decided to study the in vivo and in vitro eﬀects of Hha
point mutants in which cysteine 18 has been replaced by isoleu-
cine (HhaI), alanine (HhaA), and serine (HhaS) and compare
them with the native protein (Hhawt). Alanine is often used
to probe the eﬀect of a particular side chain, and serine is a
conservative replacement often used to avoid complicationsblished by Elsevier B.V. All rights reserved.
Fig. 1. Hha structure (PDB ﬁle 1JW2). The position of Cys18 is
indicated.
3140 T.N. Cordeiro et al. / FEBS Letters 582 (2008) 3139–3144arising from the reactivity of the thiol group. In addition,
chemical modiﬁcation of the cysteine side chain with a para-
magnetic probe was used to conﬁrm the preservation of the
structure and H–NS binding activity of Hha proteins modiﬁed
at residue 18.2. Materials and methods
2.1. Bacterial strains, plasmids and culture conditions
E. coli strains 5K and Hha3 (hha::Tn5) have been previously de-
scribed [11]. Plasmid pET15bHisHha is derived from pET15b where
a PstI/XbaI digested fragment from pET3bHisHha, containing the his-
hha sequence, was introduced.
Site-directed mutagenesis was performed using the QuikChange site-
directed mutagenesis kit (Stratagene). The plasmids used are listed in
Table 1.
Luria–Bertani (LB) medium (10 g/l tryptone, 10 g/l NaCl, 5 g/l yeast
extract) was routinely used in this work. When required, the NaCl con-
centration was decreased to 0 M.
2.2. Protein expression and puriﬁcation
Recombinant Hha and H–NS64 proteins were expressed using plas-
mids pET15bHisHha2 and pET15bHNS64His and puriﬁed as de-
scribed [9].
For pull-down experiments, isopropyl b-D-thiogalactoside (IPTG)-
induced BL21(DE3) cells containing plasmids pET15bHisHha,
pET15bHisHhaC18I, pET15bHisHhaC18A or pET15bHisHhaC18STable 1
Plasmid descriptions
Plasmid Description Source or
reference
pET3bHisHha pET3b + 6·his-hha; Apr [6]
pET15bHisHha pET15b + 6·his-hha; Apr This work
pET15bHisHha2a pET15b + 6·his-TEV-hha; Apr [8]
pET15bHNS64His pET15b + hns64-6·his; Apr [9]
pUBM22 pBR322 + hha; Apr [6]
pUBM22C18I pBR322 + hha C18I; Apr This work
pUBM22C18S pBR322 + hha C18S; Apr This work
pUBM22C18A pBR322 + hha C18A; Apr This work
pET15bHisHhaC18I pET15bHisHha C18I; Apr This work
pET15bHisHhaC18S pET15bHisHha C18S; Apr This work
pET15bHisHhaC18A pET15bHisHha C18A; Apr This work
pCB26 pANN202-312 hlyC::lacZ; Cmr [18]
aThe expressed sequence is MGSS(H)6SSGRENLYFQGH(Hha)GS
and contains a recognition site (ENLYFQG) for tobacco etch virus
(TEV) protease.were lysed in 20 mM HEPES (pH 7.9), 100 mM KCl, 5 mM MgCl2,
0.5 mM DTT (dithiothreitol), 20 mM imidazole. His-tagged Hha pro-
teins were puriﬁed from the soluble extract with Ni2+-NTA beads (Qia-
gen). Western blot analysis of proteins transferred to nitrocellulose
membranes was performed with polyclonal antibodies raised against
E. coli H–NS.2.3. Measurement of hemolysin expression
Hemolysin expression was evaluated by b-galactosidase activity as
previously described [12], using the plasmid pCB26 (hlyC::lacZ).
2.4. Fluorescence anisotropy titrations
Steady-state ﬂuorescence anisotropy measurements were carried out
with a PTI QuantaMaster spectrophotometer in a T-format setup,
using an excitation wavelength of 295 nm, to selectively excite the
Hha tryptophan, and acquiring the resulting emission at 344 nm. Each
point is the average of 180 measurements, using an integration time of
1 s, and with an independent determination of G-factor. Excitation and
emission slits were both adjusted to 5 nm.
Titrations were performed at 25 C with freshly puriﬁed proteins, in
the presence of 20 mM sodium phosphate (pH 7.0), 50 mM NaCl, 1
mM tris(2-carboxyethyl)-phosphine (TCEP), 0.2 mM EDTA, 0.01 %
(w/v) NaN3.
2.5. NMR spectroscopy
NMR data were acquired at 25 C on a Bruker Avance 600 MHz or
a Bruker DMX-500 MHz spectrometers. Binding experiments of 15N-
labelled Hhawt and HhaI (80–90 lM) with H–NS64 were performed in
20 mM sodium phosphate (pH 7.0) containing 150 mM NaCl, 1 mM
TCEP, 0.2 mM EDTA, 0.01 % (w/v) NaN3.
Speciﬁc assignments for the 1H–15N–HSQC cross-peaks of HhaI
were obtained using a combination of 3D-NOESY-HSQC and TOC-
SY-HSQC experiments acquired from an 800 lM sample, with mixing
times of 140 and 60 ms, respectively.
2.6. Circular dichroism: GdmHCl denaturation
Chemical denaturation curves were recorded on a Jasco J-810 spec-
trometer monitoring the absorption at 222 nm and carried out by step-
wise mixing a protein solution with 6 M GdmCl into a protein solution
with no denaturant. At each step the sample was stirred for 45 s, let
equilibrate for 3 min, and then a measurement averaged for 60 s was
recorded. These experiments were done at 25 C at protein concentra-
tions between 20 and 25 lM in 20 mM sodium phosphate (pH 7.0),
150 mM NaCl, 1 mM TCEP. The change in free energy upon unfold-
ing was determined as previously described [13,14].
The contribution that hydrophobic buried residues make to the pro-
tein stability can be estimated using the free energy of transfer of ami-
no acids form organic solvents to water, DGtransfer [15]. Assuming that
in the unfolded chain the site of mutation is fully exposed to the sol-
vent and in the folded state is equally shielded, independently of the
residue, the experimental unfolding free energy, DGU-F, can been cor-
rected using the following equation,
DGU-F ¼ DGU-F þ ð1 vcysÞDDGtransfer ð1Þ
in which DGU-F is the corrected unfolding free energies and vcys repre-
sents the fraction of Cys18 solvent accessible surface area in the Hha
folded state (46.6%). The free energy DDGtransfer denotes the diﬀerence
between tabulated transfer free energy of Cys residue, DGCystransfer and
those in the Hha mutants structures at position 18, DGXtransfer (being
X = Ala or Ileu), i.e. DDGtransfer ¼ DGCystransfer  DGXtransfer.3. Results
3.1. HhaI does not complement the hha phenotype and reduces
the bacterial growth rate at low ionic strength
The H–NS/Hha complex is responsible for the eﬃcient
repression of the hly operon encoding the E. coli hemolysin vir-
ulence factor [6,16,17]. Repression was measured using plas-
mid pCB26 that contains the b-galactosidase gene fused to
the hlyC gene (hlyC::lacZ [12]). This plasmid was transformed
Fig. 3. Growth curves at 37 C in salt-free LB of Escherichia coli 5K
transformed with plasmids expressing Hhawt, HhaI, HhaS or HhaA or
untransformed. Note the logarithmic scale.
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Hha, the hly operon is partially derepressed. Strain Hha3-
(pCB26) was transformed with plasmids expressing either
Hhawt (pUBM22), HhaI (pUBM22C18I), HhaA (pUB-
M22C18A), or HhaS (pUBM22C18S).
As expected, plasmid pUBM22, that contains the wild-type
hha gene, complements the hha mutation of strain Hha3 and
reduces hemolysin expression. This was also the case for plas-
mids pUBM22C18S and pUBM22C18A. In contrast, plasmid
pUBM22C18I failed to complement the hha phenotype
(Fig. 2). Thus, HhaI is unable to repress the expression of
the hly operon.
The Hha protein has been related to the thermo- and osmo-
regulation of gene expression [17]. We decided to test the eﬀect
of Hha mutants in the growth of E. coli under diﬀerent osmo-
larity conditions. Whereas growth in the presence of medium-
to-high osmolarity conditions was not signiﬁcantly aﬀected by
the presence of the diﬀerent mutant derivatives (data not
shown), in salt-free LB medium, expression of HhaI in E. coli
strain 5K, but not of HhaA or HhaS, signiﬁcantly reduced the
growth rate (Fig. 3). Considering that strain 5K expresses
Hhawt, we also tested the eﬀect of plasmid pUBM22C18I in
the hha mutant strain Hha3 and we observed the same eﬀect
(results not shown).3.2. Point mutations of cysteine 18 in Hha gives stable, well
folded proteins
HhaI HSQC NMR spectra are similar to those of Hhawt and
consistent with a well folded, monomeric protein with a similar
overall structure (compare Fig. 4A and B).
The relative stabilities were measured by circular dichroism
in the presence of increasing concentrations of guanidinium
chloride (GdmHCl). The free energies of unfolding ðDGUFÞ
of Hhawt, HhaI and HhaA are 3.74 ± 0.06, 4.23 ± 0.09 and
2.82 ± 0.05 kcal/mol, respectively. The observed changes in
stability can be nearly fully accounted for by considering the
solvent transfer energy of the diﬀerent side chains and their dif-
ferent degree of exposure in the folded and unfolded states (see
Section 2). After correction, the change in unfolding free
energy between the mutants and the wild-type form are
0.022 kcal/mol (CysﬁAla) and 0.39 kcal/mol, (CysﬁIle)
suggesting similar foldings.Fig. 2. Expression of b-galactosidase from a hly::lacZ gene reporter in
the hha mutant strain Hha3 (pCB26) (black) and in strains cotrans-
formed (diﬀerent shades of grey) with plasmids expressing Hhawt,
HhaI, HhaS and HhaA.3.3. H–NS binding to Hha is not substantially aﬀected by
mutations of Cys18
As a ﬁrst approach to determine whether H–NS is able to
interact with the diﬀerent Hha variants studied we used pull-
down experiments. Recombinant His-tagged Hhawt, HhaI,
HhaS, and HhaA were expressed in BL21(DE3) cells and the
bacterial lysates were incubated with Ni2+-NTA beads. Wes-
tern blot analysis indicated that a considerable amount of cel-
lular untagged H–NS was co-puriﬁed with all the Hha variants
indicating that all of them bind H–NS to some extent (Fig. 5).
Addition of increasing amounts of KCl caused dissociation of
the Hha-H–NS complex, and release of H–NS. Binding is
weakest to HhaA and strongest to HhaI, as seen from the salt
concentration needed to dissociate the complex. H–NS
complexes with Hhawt and HhaS show similar intermediate
stabilities.
In vitro binding of the H–NS N-terminal domain to Hhawt
and HhaI was studied at constant salt by steady-state intrinsic
ﬂuorescence anisotropy. Fig. 6 shows ﬂuorescence anisotropy
titrations of Hhawt and HhaI with H–NS64. Complex forma-
tion increases the correlation time and causes an increased
anisotropy. Titration of both Hha variants reaches a plateau
with very similar anisotropy values indicating the formation
of a complex of similar size. In agreement with the previous re-
sults, both Hha variants showed comparable H–NS binding
aﬃnities, although the aﬃnity of the C18I mutant is slightly
higher (Kd = 8.4 lM versus 19.4 lM).
Further evidence supporting the formation of analogous
heterocomplexes between either Hhawt or HhaI and the N-ter-
minal domain of H–NS was obtained by NMR. Addition of
unlabelled H–NS64 to
15N-labelled samples of either Hhawt
or HhaI induced selective broadening of HSQC peaks corre-
sponding to the same residues in both cases, indicating that
most protein–protein interactions are preserved and analogous
heterocomplexes were formed between the H–NS N-terminal
domain and both Hha variants (Fig. 4).
NMR signals corresponding to residue 18 and adjacent posi-
tions are not among the most aﬀected ones upon H–NS64 addi-
tion (Fig. 4), suggesting that residue 18 is not directly involved
in H–NS binding. This was conﬁrmed by the incorporation of
a paramagnetic spin label ((1-oxyl-2,2,5,5-tetramethyl-3-pyrro-
line-3-methyl)-methanethiosulfonate (MTSL)) to the cysteine
side chain. The MTSL modiﬁed Hha retained the capacity to
bind H–NS64 but the paramagnetic probe did not induce any
Fig. 4. HSQC NMR spectra. (A and C) Hhawt. (B and D) HhaI. (A,B) without H–NS64. (C and D) in the presence of 0.5 equivalents of H–NS64.
Residues showing more than 75% reduction in their intensity in the presence of H–NS64 are indicated in the spectra of the free proteins. The
additional residues (Y44 and R50) marked in the spectra of HhaI are also aﬀected in Hhawt, although their intensity is above the 75% threshold in the
presence of only 0.5 equiv. of H–NS64.
Fig. 5. (A) H–NS immunodetection in eluted fractions from a Ni2+–NTA agarose resin loaded with diﬀerent his-tagged Hha variants. Lane 1:
Unbound supernatant. Eluates with increasing salt concentrations: 0.1 M KCl (lanes 2–4), 0.5 M KCl (lanes 5 and 6), 1 M KCl (lane 7), 2 M KCl
(lane 8). Lane I: 0.5 M imidazole. (B) Normalized intensities with respect to the total eluate.
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labelled H–NS N-terminal domain (results not shown), con-ﬁrming that Cys18 of Hha is not in the proximity of H–NS
in the heterocomplex.
Fig. 6. Fluorescence anisotropy titrations of 4 lM samples of Hhawt
(open triangles) and HhaI (ﬁlled circles) with H–NS64 at 50 mM NaCl.
The solid curves are the best ﬁt to a model assuming the binding of one
Hha molecule to one H–NS64 dimer with dissociation constants of
19.4 lM (Hhawt) and 8.4 lM (HhaI).
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Mutation of cysteine 18 to isoleucine, but not to alanine or
serine, generates a phenotype that has lost the characteristic
ability of wild-type Hha to repress the expression of the hly op-
eron under standard test conditions and to grow eﬃciently at
low osmolarity. These results clearly identify the locus of cys-
teine 18 as a key element for the in vivo function of Hha. How-
ever, the cysteine side chain is not required as mutations to
alanine or serine do not produce any observable phenotype
in vivo.
The mutations introduced at position 18 had negligible ef-
fects in the structure and stability of Hha as shown by NMR
and guanidinium denaturation studies.
Several experimental evidences suggest that Cys18 is not di-
rectly involved in H–NS binding. First, Cys18 NMR signals
are not among the most aﬀected ones by H–NS binding. Sec-
ond, incorporation of a paramagnetic probe at position 18 of
Hha did not produce paramagnetic relaxation enhancement
in the NMR spectra of the H–NS N-terminal domain. Third,
complexation was not signiﬁcantly aﬀected by replacing the
cysteine side chain by polar (Ser) or non-polar (Ala or Ile) side
chains or by adding a large group (MTSL) to the thiol. Con-
sistently, ﬂuorescence anisotropy, indicating similar complex
size, and the perturbation of the same NMR signals of Hhawt
and HhaI by H–NS64 suggest that analogous complexes are
formed.
The small diﬀerences in stability of the complexes with H–
NS do not explain the diﬀerent phenotypes between HhaI in
one hand and Hhawt, HhaA, and HhaS on the other hand.
HhaA forms a less stable complex than Hhawt but is able to res-
cue the hha mutant in the repression of the hly operon. How-
ever, HhaI, that forms the most stable complex both with full
length H–NS and with H–NS64, does not compensate for the
absence of Hhawt in spite of the fact that heterocomplexes
formed between Hha and H–NS repress hly transcription more
eﬃciently than H–NS oligomers alone [17].
The reduced growth rate of HhaI at low ionic strength may
reﬂect the loss of adaptability of the cell caused by an ineﬃ-
cient regulation of gene transcription. It is observed both in
the presence and in the absence of wild-type Hha. However,
no measurable interaction could be observed between HhaI
and Hhawt by NMR (results not shown) showing that the eﬀectof HhaI is not due to an interaction between both Hha forms.
Other eﬀects in some unknown(s) function(s) of Hha cannot be
excluded. Evaluation of these possibilities is beyond the scope
of this study and will require further investigation.
The Hha paralogue YdgT, which has 38% identity and 67%
similarity to Hha has an isoleucine residue at position 18 and
forms strong complexes with H–NS [10]. However, transfor-
mation of E. coli strains with a plasmid expressing YdgT does
not have any detectable phenotype at low salt concentration
(data not shown). Possible explanations for the diﬀerent eﬀects
of YdgT and HhaI could be related to the existence of indepen-
dent control mechanisms for the naturally occurring YdgT
protein that are not acting on the Hha mutant or to diﬀerent
functional roles of Hha and YdgT. Alternatively, one could
speculate that additional diﬀerences between Hha and YdgT
may give rise to the formation of an active complex of YdgT
with H–NS even in the presence of isoleucine in the loop be-
tween helices 1 and 2.
In conclusion, the large diﬀerence between HhaI and Hhawt
in the capacity to co-repress with H–NS the expression of the
hly operon is surprising in view of the equivalence between the
heterocomplexes formed between H–NS and both Hha vari-
ants. These results suggest that the mechanism of action of
Hha is more complex than previously thought and Hha does
not simply regulate H–NS function by masking or unmasking
speciﬁc regions of H–NS. Instead, or in addition to, regions of
Hha outside the H–NS binding site play a speciﬁc role in the
activity of the Hha/H–NS complex actively contributing to
the regulation process.
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